UNSPSC 85445106: The diagnosis of valproic acid

In this classification, this covers the group of activities that yields a diagnosis of valproic acid. Valproic acid is listed In The World Health Organization's International Statistical Classification of Diseases and Related Health Problems (ICD-10) as a four-character category under code Y46.5.

UNSPSC 85445106 The diagnosis of valproic acid is a Commodity code, but the recent state and local opportunities tagged under it do not reflect diagnostic laboratory testing or pharmaceutical analysis. Instead, the three most recent solicitations address unrelated clinical services: diagnostic imaging system infrastructure (San Mateo Medical Center PACS procurement), special education contracted clinical services across school campuses (Birdville Independent School District), and temporary health professional staffing across multiple ancillary clinical categories (Santa Clara County Health System). The code shows little relevant recent activity in state and local procurement aligned with its stated scope of valproic acid diagnostic services.

The geographic spread of the three opportunities spans California (San Mateo County, Santa Clara County) and Texas (Tarrant County). San Mateo Medical Center posted an RFP for Diagnostic Imaging PACS due October 21, 2026, seeking enterprise-grade system implementation with EPIC integration to support approximately 65,000 radiology studies, 5,000 cardiology studies, and 8,000 mammography interpretations annually. Birdville Independent School District posted a competitive sealed proposal for special education contracted services due October 21, 2026, covering 23 line items including audiologist, diagnostician, dyslexia evaluator, and multiple therapy specialties across 30 campuses serving over 24,300 students, with a cost-price analysis of $398,494.30 and a contract term through November 30, 2027. Santa Clara County Health System solicited proposals to establish a qualified vendor pool for temporary health professional staffing across 13 ancillary clinical categories, due October 7, 2026, on a non-exclusive, multiple-award basis with no guaranteed work volume and a five-year Qualified List term. None of these opportunities directly addresses valproic acid diagnostic services.